Detalhe da pesquisa
1.
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature
; 606(7915): 797-803, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705814
2.
Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature
; 613(7945): E3, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36627494
3.
Depression severity in electroconvulsive therapy (ECT) versus pharmacotherapy trials.
J ECT
; 31(1): 31-3, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24839981
4.
Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases.
Clin Cancer Res
; 29(3): 521-531, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477181
5.
Improved pyrexia-related outcomes associated with an adapted pyrexia adverse event management algorithm in patients treated with adjuvant dabrafenib plus trametinib: Primary results of COMBI-APlus.
Eur J Cancer
; 163: 79-87, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042070
6.
Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.
Prostate
; 71(7): 755-65, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21031435
7.
Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancers.
Eur J Cancer
; 153: 234-241, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34225229
8.
A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Individual Patient Program (DESCRIBE III).
Cancers (Basel)
; 13(10)2021 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34070224
9.
A phase 3 randomized study (HOMER) of ofatumumab vs rituximab in iNHL relapsed after rituximab-containing therapy.
Blood Adv
; 4(16): 3886-3893, 2020 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810220
10.
Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study.
Blood Cancer J
; 9(12): 98, 2019 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31801940
11.
Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell Carcinoma.
Clin Cancer Res
; 24(13): 3005-3013, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29330204
12.
LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer.
PLoS One
; 11(1): e0146549, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26771192
13.
A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial.
Leuk Lymphoma
; 61(7): 1748-1751, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107948
14.
Cotinine levels among betel quid users and cigarette smokers in Cambodia.
Asia Pac J Public Health
; 25(5 Suppl): 84S-91S, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24092815
15.
Expression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor types.
PLoS One
; 7(1): e30132, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22276150